# Experience With Topical Acne Treatment

> **NCT05582434** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 72 (actual)

## Conditions studied

- Acne

## Interventions

- **DRUG:** clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel
- **DRUG:** adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel
- **DRUG:** Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel

## Key facts

- **NCT ID:** NCT05582434
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-15
- **Primary completion:** 2025-06-19
- **Final completion:** 2026-11
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582434, "Experience With Topical Acne Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05582434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*